AnaptysBio, Inc.

ANAB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$53.66+0.56%

2026-08-03

Financials

Valuation Metrics

AnaptysBio, Inc.'s Market Cap is $1.56B. At end of 2025 it was $1.35B. Ranked #2212 of 3,111 in US market (top 71%), #873 of 1,445 on NASDAQ (top 60%), #161 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 60%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.56B	US#2,212/3,111 Sec#161/269
Revenue	$232M	US#2,647/3,111 Sec#107/269
Net Income	$-27M	US—/3,111 Sec—/269
Total Assets	$330M	US#2,882/3,111 Sec#202/269
Net Assets	$13M	US#2,997/3,111 Sec#259/269
Value
P/B	122.50x	US#2,970/3,111 Sec#261/269
P/S	6.72x	US#2,483/3,111 Sec#102/269
EV/EBITDA	27.19x	US#2,112/3,111 Sec#64/269
FCF Yield	0.28%	US#2,217/3,111 Sec#83/269
Profitability
ROA	-8.13%	US#2,620/3,111 Sec#99/269
Op. Margin	17.56%	US#1,073/3,111 Sec#46/269
Revenue Growth	-7.98%	US#2,623/3,111 Sec#144/269
Financial Health
Debt Ratio	2486.37%	US#2,932/3,111 Sec#259/269
Total Debt	$277M	US#2,098/3,111 Sec#81/269
FCF	$4M	US#2,237/3,111 Sec#83/269
Cash	$248M	US#1,564/3,111 Sec#96/269
Current Ratio	7.58x	US#308/3,111 Sec#102/269
Net Debt/EBITDA	0.49x	US#807/3,111 Sec#43/269
Performance
1Y Return	117.33%	US#224/3,111 Sec#70/269
1M Return	-15.39%	US#2,802/3,111 Sec#233/269
From 52W High	-26.79%	US#1,997/3,111 Sec#146/269
1Y MDD	-36.50%	US#1,775/3,111 Sec#125/269
Trading
Volume	421,254 shares	US#2,114/3,111 Sec#211/269
Trading Value	$22M	US#1,825/3,111 Sec#133/269
Per Share
EPS	$-0.48	US—/3,111 Sec—/269
BPS	$1.34	US#2,584/3,111 Sec#193/269